rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ADCT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ADC Therapeutics at guggenheim healthcare conference: data and runway improve
      Nov 10Investing.comADCT
      ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
      Nov 9Yahoo FinanceADCT
      ADC Therapeutics SA (ADCT) Discusses ZYNLONTA Data at ASH and Strategic Financial Restructuring - Slideshow
      Nov 7Seeking AlphaADCT
      ADC Therapeutics Reports Strong Lymphoma Responses, Plans Phase III Study
      Nov 4Yahoo FinanceADCT
      ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program
      Nov 4Yahoo FinanceADCT
      ADC Therapeutics to Present at November Investor Conferences
      Nov 3MorningstarADCT
      ADC Therapeutics to Announce Third Quarter 2026 Financial Results on November 9, 2026
      Nov 2Yahoo FinanceADCT
      ADC Therapeutics partner files for Japan approval of ZYNLONTA
      Oct 29Investing.comADCT
      ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says
      Oct 9Yahoo FinanceADCT
      ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis
      Oct 9Seeking AlphaADCT
      ADC Therapeutics Shares Rise After Financial Restructuring Extends Cash Runway
      Oct 8Yahoo FinanceADCT
      ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
      Oct 8MorningstarADCT
      ADC Therapeutics SA (ADCT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
      Sep 12Seeking AlphaADCT
      ADC Therapeutics at Cantor conference: zynlonta growth plan faces FDA test
      Sep 11Investing.comADCT
      ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
      Sep 3MorningstarADCT
      Styx Biotechnologies Announces Strategic Agreement with ZoeNCure Therapeutics to Accelerate Next-Generation ADC Pipeline to Clinic
      Sep 1Yahoo FinanceADCT
      ADC Therapeutics (ADCT) Navigates FDA Setback While Cutting Its Losses

      On August 13, ADC Therapeutics (NYSE:ADCT) held its second-quarter earnings call and delivered a mixed message that investors are still sorting through. The company’s confirmatory trial for ZYNLONTA in second-line lymphoma cleared its main efficacy bar, but the FDA has flagged serious safety concerns about the combination that could complicate its path to a fuller […]

      Aug 27Yahoo FinanceADCT

      This is the newest page. Registered accounts read further back.